Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.97
Market cap: ₹8,053 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.3×Sector 47.3×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

23 Apr 2026 15:53 IST NSE

Morepen Laboratories Debt & Borrowing: ₹30 Cr

Morepen Laboratories Limited has secured a ₹30 Crore unsecured term loan from Shinhan Bank. The facility carries an interest rate of 7.60% (Repo + 2.35% spread) with a 36-month tenure. The funds will be utilized for general business purposes, with repayment in 10 quarterly instalments after a 6-month moratorium.

Value: ₹30.00 Cr
Execution: 36 months

Read the filing ↗

23 Apr 2026 15:49 IST NSE

Debt & Borrowing

Morepen Laboratories Debt & Borrowing: ₹30 Cr

Morepen Laboratories Limited has secured a ₹30 Crore unsecured term loan from Shinhan Bank for general business purposes. The facility has a tenure of 36 months with a 6-month moratorium and is backed by a personal guarantee from the Chairman. This financing strengthens the company's liquidity position.

Value: ₹30.00 Cr
Execution: 36 months

Read the filing ↗